FRONTEO succeeds in developing a new function that enables the fall prediction AI system "Coroban" to be used in nursing care facilities

Home » corporate » News » 2022 » FRONTEO succeeds in developing a new function that enables the fall prediction AI system "Coroban" to be used in nursing care facilities
2022.02.21 Press release

--To the press -

FRONTEO succeeds in developing a new function that enables the fall prediction AI system "Coroban" to be used in nursing care facilities

FRONTEO Inc.
Masahiro Morimoto, President and CEO
2-12-23 Konan, Minato-ku, Tokyo
(Code number: 2158 TSE Mothers)

 FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereafter FRONTEO) has developed a new function of the fall prediction AI system "Coroban", and the system is in the electronic medical record of medical institutions. In addition to analysis based on records, we are pleased to inform you that it is now possible to analyze fall predictions based on nursing records at nursing facilities.

 

 Coroban utilizes the natural language processing AI engine "Concept Encoder (trademark: conceptencoder, reading: concept encoder)" originally developed by FRONTEO to predict the risk of falling from the nursing records written in the electronic medical record and display an alert. It is a system to do. Development began in 2016, and sales to medical institutions began in 2019 with Eisai Co., Ltd., and it is currently being introduced at medical institutions. Obtained a patent in January 2020 (patent registration number: Patent No. 1), and in March of the same year, it was certified as a recommended product by the Japan Society for Fall Prevention.

 

 Until now, the analysis target of this system has been the nursing record in the electronic medical record, but the function has been expanded and it is possible to predict falls with almost the same accuracy even in the nursing record recorded in the nursing facility. I did.

 

 Falling / falling of elderly people not only leads to the need for long-term care / bedtime and the progression of dementia, but also has the risk of death. Equally important, various measures have been taken.On the other hand, it is more difficult than medical institutions to prevent falls in long-term care facilities, which are also a place of living, and it is difficult to deal with them in the field, which is one of the important issues in long-term care. increase.

 

 FRONTEO believes that this expansion of Coroban's functions will help solve this problem. FRONTEO will continue to contribute to improving the QOL of people in a super-aging society by providing solutions for solving problems in medical and long-term care settings through research and development of AI systems.

 


■ About Coroban
 URL:https://lifescience.fronteo.com/aidevice/coroban/
Coroban is a fall prediction AI system developed by FRONTEO in collaboration with Eisai Inc. FRONTEO's natural language analysis AI "Concept Encoder" reads electronic medical records and evaluates the risk of falling from the patient's condition and nursing records.It is possible to make predictions with the same accuracy as the conventional fall / fall risk assessment sheet without increasing the burden on medical staff and without increasing the burden on medical staff.Recommended by the Japan Fall Prevention Society.Patent registration number: Patent No. 6652986
* This system is not a medical device.This system predicts the risk of falls and is not intended for the judgment of doctors and nurses.

■ About Concept Encoder URL:https://lifescience.fronteo.com/technology/conceptencoder/
"Concept Encoder" is a natural language analysis AI (artificial intelligence) developed by FRONTEO specially in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence. Concept Encoder can be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vitals, and various test values ​​accumulated in the life science field.Patent registration number: Patent No. 6346367

■ About FRONTEO URL:https://www.fronteo.com/
FRONTEO uses the in-house developed AI engines "KIBIT", "Concept Encoder", and "Looca Cross" that specialize in natural language processing to extract meaningful and important information from a huge amount of text data, and is a company. It is a data analysis company that supports the business of. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support corporate international litigation. Has been deployed.Based on the AI ​​technology cultivated in this business, we will expand the business field to the life science field, business intelligence field, and economic security from 8, and by using AI to "turn text data into knowledge", We contribute to solving various corporate issues such as drug discovery support, dementia diagnosis support, financial, personnel, and sales support. Listed on TSE Mothers on June 2014, 2007. Obtained a first-class medical device manufacturing and sales business license in January 6 (permit number: 26B2021X1), and notified the managed medical device sales business in September of the same year (notification number: 13 Minato Misei Equipment No. 1).The capital is 10350 thousand yen (as of March 9, 3).

* FRONTEO, conceptencoder, and KIBIT are registered trademarks of FRONTEO in Japan.
* Coroban is a registered trademark of Eisai Co., Ltd. and FRONTEO.

<Contact information for the press>

PR Department, FRONTEO, Inc.

Email: pr_contact@fronteo.com

 

Inquiries concerning Life Science AI Business

Life Science AI Business Department, FRONTEO, Inc.

https://lifescience.fronteo.com/contact